[go: up one dir, main page]

AU2003230767A8 - Methods of promoting cell viability - Google Patents

Methods of promoting cell viability

Info

Publication number
AU2003230767A8
AU2003230767A8 AU2003230767A AU2003230767A AU2003230767A8 AU 2003230767 A8 AU2003230767 A8 AU 2003230767A8 AU 2003230767 A AU2003230767 A AU 2003230767A AU 2003230767 A AU2003230767 A AU 2003230767A AU 2003230767 A8 AU2003230767 A8 AU 2003230767A8
Authority
AU
Australia
Prior art keywords
methods
cell viability
promoting cell
promoting
viability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230767A
Other versions
AU2003230767A1 (en
Inventor
Clifford J Steer
Walter C Low
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU2003230767A8 publication Critical patent/AU2003230767A8/en
Publication of AU2003230767A1 publication Critical patent/AU2003230767A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
AU2003230767A 2003-04-02 2003-04-02 Methods of promoting cell viability Abandoned AU2003230767A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/009819 WO2004096123A2 (en) 2003-04-02 2003-04-02 Methods of promoting cell viability

Publications (2)

Publication Number Publication Date
AU2003230767A8 true AU2003230767A8 (en) 2004-11-23
AU2003230767A1 AU2003230767A1 (en) 2004-11-23

Family

ID=33415179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230767A Abandoned AU2003230767A1 (en) 2003-04-02 2003-04-02 Methods of promoting cell viability

Country Status (5)

Country Link
EP (1) EP1615497A2 (en)
JP (1) JP2006514097A (en)
CN (1) CN1770975A (en)
AU (1) AU2003230767A1 (en)
WO (1) WO2004096123A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
RU2428987C2 (en) 2004-08-30 2011-09-20 Сео Хонг Ю Neuroprotective action of soluble ursodeoxycholic acid in models of focal ischemia
CN101039699B (en) 2004-10-15 2011-07-27 柳署弘 Methods and compositions for reducing toxicity of a pharmaceutical compound
WO2014036379A2 (en) * 2012-08-31 2014-03-06 Metselex Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
US9872865B2 (en) 2013-03-24 2018-01-23 Amylyx Pharmaceuticals Inc. Compositions for improving cell viability and methods of use thereof
WO2015001379A1 (en) * 2013-07-01 2015-01-08 Bruschettini S.R.L. Tauroursodeoxycholic acid (tudca) for use in the treatment of neurodegenerative disorders
CN109628379A (en) * 2018-12-18 2019-04-16 西安交通大学 A kind of animal cloning embryo medium and cultural method
US11583542B2 (en) 2019-12-16 2023-02-21 Amylyx Pharmaceuticals, Inc. Compositions of bile acids and phenylbutyrate compounds
CN116262121A (en) * 2021-12-15 2023-06-16 南湖实验室 Use of tauroursodeoxycholic acid and its sodium salt in anti-aging and/or life extension
US12138272B2 (en) 2022-05-12 2024-11-12 Amylyx Pharmaceuticals, Inc. Methods and compositions for treating amyotrophic lateral sclerosis

Also Published As

Publication number Publication date
WO2004096123A3 (en) 2005-04-14
EP1615497A2 (en) 2006-01-18
CN1770975A (en) 2006-05-10
JP2006514097A (en) 2006-04-27
WO2004096123A2 (en) 2004-11-11
AU2003230767A1 (en) 2004-11-23

Similar Documents

Publication Publication Date Title
GB2404665B (en) Cell culture
IL184262A0 (en) Cell culture method and utilization of the same
GB0329449D0 (en) Stem cells
IL172988A0 (en) Bioreactor
AU2003260351A8 (en) Cell culture insert
EP1625832A4 (en) Method of removing cell
EP1794829A4 (en) Improved lithium cell and method of forming same
AU2003216822A8 (en) Stem cell culture
EP1743025A4 (en) Methods for production of regulatory t cells and uses thereof
GB2413564B (en) Cell culture carriers
AU2003230767A8 (en) Methods of promoting cell viability
GB2422843B (en) Cell culture base
GB0426182D0 (en) Photoporation of cells
ZA200506732B (en) Cell culture
ZA200702966B (en) Cryopreservation of cells
IL177647A0 (en) Use of enzyme
GB0315262D0 (en) Methods of cell culture
GB2408702B (en) Bioreactor
GB2394477B (en) Cell culture
GB0314561D0 (en) Cell culture
GB0319804D0 (en) Cell culture method
IL158173A0 (en) Nanopatch-containing cells
IL178683A0 (en) Methods of diminishing co-abuse potenitial
EP1443114A4 (en) Method of cell culture
GB0301834D0 (en) Methods employing cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase